AGM/EGMMay 11, 2026, 05:12 PM
Ernexa Therapeutics to Hold Annual Meeting July 1; Seek Plan Approval
AI Summary
Ernexa Therapeutics Inc. announced its 2026 annual meeting of stockholders will be held virtually on July 1, 2026, at 11:00 a.m. Eastern Time. Shareholders of record as of May 6, 2026, will vote on the election of five director nominees, the ratification of Haskell & White LLP as the independent registered public accounting firm for 2026, and the adoption of the 2026 Omnibus Equity Incentive Plan. The company's board of directors recommends voting "FOR" all proposals.
Key Highlights
- Annual Meeting of Stockholders scheduled for July 1, 2026, at 11:00 a.m. ET.
- Meeting will be held virtually at virtualshareholdermeeting.com/ERNA2026.
- Stockholders will vote to elect five nominees to the board of directors.
- Ratification of Haskell & White LLP as independent auditor for 2026 fiscal year.
- Approval sought for the adoption of the 2026 Omnibus Equity Incentive Plan.
- Record date for voting is May 6, 2026.
- 1,166,333 shares of common stock were outstanding as of the record date.
- Board of directors recommends voting "FOR" all proposals.
Price Impact
More from ERNA